CRF2 Agonism Shows Potential in Obesity Treatment with Muscle and Glucose Benefits | Retatrutide News

Pharmacological CRF2 agonism may enhance fat loss and muscle growth in obesity models. This could inform future obesity treatments alongside GLP-1 agoni...
Weight Loss · November 1, 2026